Supermicro Expands Collaboration with NVIDIA and Strengthens Compliance, Data Integrity, and Quality of U.S.-Based Manufacturing of AI Infrastructure Solutions Optimized for Government Applications
Deepening collaboration with NVIDIA to bring NVIDIA Vera Rubin NVL144 and NVIDIA…
ST Telemedia Global Data Centres (India) Signs Memorandum of Understanding with Maharashtra Government forInvestment of Up to INR 5,000 Crore
ST Telemedia Global Data Centres (India) (STT GDC India), a leading co-location…
Business Sentiment Softens in Q4 Amid Global Uncertainty, while Domestic Orders Show Continued Resilience
The Dun & Bradstreet Business Optimism Index India declined by 1.9% (q-o-q)…
Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular…
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT…
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ --Â ACMÂ Biolabs, a clinical-stage biotechnology company developing next-generation…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Dun & Bradstreet Honours Public Sector Excellence at the PSU & Government Summit 2025
MUMBAI, India, Oct. 23, 2025 /PRNewswire/ -- Dun & Bradstreet, a leading…